Skip to content

Citius Oncology, Inc.

CTOR Nasdaq SEC CIK 1851484

Follow Citius Oncology Weekly email: filings, results, news

News

2 stories filed under Citius Oncology

Citius Oncology shares tumble as Q3 revenue misses forecasts despite LYMPHIR launch momentum

Earnings 38 d ago

Citius Oncology appoints Jonathan Peri to board of directors

Markets 43 d ago

Profile

Headquarters: CRANFORD, NJ, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 2 stories clustered from the RSS aggregator